Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiaki Taniyama

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2006
[Development of plasmid DNA-based gene transfer]Yoshiaki Taniyama, Ryuichi Morishita
Journal of Molecular and Cellular Cardiology|October 24, 2002
Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growthYoshiaki Taniyama, Kenneth Walsh
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Therapeutic angiogenesis for diabetes mellitus related ischemic disease]Yoshiaki Taniyama, Fumihiro Sanada, Ryuichi Morishita
Current Gene Therapy|October 26, 2011
Plasmid DNA-based gene transfer with ultrasound and microbubblesYoshiaki Taniyama, Junya Azuma, Hiromi Rakugi, et al.
Journal of the American Heart Association|April 24, 2013
Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertensionHiroshi Kusunoki, Yoshiaki Taniyama, Hiromi Rakugi, et al.
Biochemical and Biophysical Research Communications|June 5, 2007
Constitutive over-expression of VEGF results in reduced expression of Hand-1 during cardiac development in XenopusKaori Nagao, Yoshiaki Taniyama, Nobutaka Koibuchi, et al.
Expert Opinion on Biological Therapy|April 29, 2014
Gene therapy for peripheral arterial diseaseMunehisa Shimamura, Hironori Nakagami, Yoshiaki Taniyama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 14, 2014
Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytesHiroshi Kusunoki, Yoshiaki Taniyama, Rei Otsu, et al.
Current Topics in Medicinal Chemistry|July 6, 2012
Development of nucleic acid drugs for neurological disordersMunehisa Shimamura, Naoyuki Sato, Hironori Nakagami, et al.
Biomedical Reports|March 21, 2014
Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout miceAmarnath Chatterjee, Hiroshi Kusunoki, Yoshiaki Taniyama, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2006
[Development of plasmid DNA-based gene transfer]Yoshiaki Taniyama, Ryuichi Morishita
Journal of Molecular and Cellular Cardiology|October 24, 2002
Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growthYoshiaki Taniyama, Kenneth Walsh
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Therapeutic angiogenesis for diabetes mellitus related ischemic disease]Yoshiaki Taniyama, Fumihiro Sanada, Ryuichi Morishita
Current Gene Therapy|October 26, 2011
Plasmid DNA-based gene transfer with ultrasound and microbubblesYoshiaki Taniyama, Junya Azuma, Hiromi Rakugi, et al.
Journal of the American Heart Association|April 24, 2013
Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertensionHiroshi Kusunoki, Yoshiaki Taniyama, Hiromi Rakugi, et al.
Biochemical and Biophysical Research Communications|June 5, 2007
Constitutive over-expression of VEGF results in reduced expression of Hand-1 during cardiac development in XenopusKaori Nagao, Yoshiaki Taniyama, Nobutaka Koibuchi, et al.
Expert Opinion on Biological Therapy|April 29, 2014
Gene therapy for peripheral arterial diseaseMunehisa Shimamura, Hironori Nakagami, Yoshiaki Taniyama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 14, 2014
Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytesHiroshi Kusunoki, Yoshiaki Taniyama, Rei Otsu, et al.
Current Topics in Medicinal Chemistry|July 6, 2012
Development of nucleic acid drugs for neurological disordersMunehisa Shimamura, Naoyuki Sato, Hironori Nakagami, et al.
Biomedical Reports|March 21, 2014
Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout miceAmarnath Chatterjee, Hiroshi Kusunoki, Yoshiaki Taniyama, et al.
Pageof 8